|
Patient-Oriented Tools for Communicating Lung Cancer Screening Results: The First of Many Critical Components
|
March 9, 2023
|
PC3I Authors Katharine Rendle; Anil Vachani |
Chest
|
|
Oral and emotional health experience of refugees’ in the state of Massachusetts – A mixed methods approach
|
March 9, 2023
|
PC3I Authors Tamara J. Cadet |
PLoS One
|
|
Could DNA Fragments Be the Key to Early Detection of Lung Cancer?
|
March 8, 2023
|
PC3I Authors Anil Vachani |
American Journal of Respiratory and Critical Care Medicine
|
|
Access for Cancer Caregivers to Education and Support for Shared Decision Making (ACCESS) intervention: a cluster cross-over randomised clinical trial
|
March 2, 2023
|
PC3I Authors George Demiris |
BMJ Supportive & Palliative Care
|
|
PI3king apart a rare disease with targeted therapy
|
March 2, 2023
|
PC3I Authors Haley Newman |
Blood
|
|
Outcomes of hepatocellular carcinoma by etiology with first-line atezolizumab and bevacizumab: a real-world analysis
|
March 2, 2023
|
PC3I Authors Ronac Mamtani |
Journal of Cancer Research & Clinical Oncology
|
|
The Coming of Age of Nucleic Acid Vaccines during COVID-19
|
March 2, 2023
|
PC3I Authors Likhitha Kolla |
mSystems
|
|
Application of Traditional Vaccine Development Strategies to SARS-CoV-2
|
March 2, 2023
|
PC3I Authors Likhitha Kolla |
mSystems
|
|
Adjuvant Atezolizumab Should Be Administered to All Patients With Programmed Death-Ligand 1 Expressing Surgically Resected Stage II to III NSCLC After Chemotherapy: In Favor
|
February 26, 2023
|
PC3I Authors Melina Marmarelis; Charu Aggarwal |
Journal of Thoracic Oncology
|
|
Combining Breast Cancer Risk Prediction Models
|
February 25, 2023
|
PC3I Authors Anne Marie McCarthy |
Cancers (Basel)
|
|
Exposure to US Cancer Drugs With Lack of Confirmed Benefit After US Food and Drug Administration Accelerated Approval
|
February 23, 2023
|
PC3I Authors Ramy Sedhom; Ronac Mamtani |
JAMA Oncology
|
|
Salivary cotinine level and treatment response in muscle invasive bladder cancer: A pilot study
|
February 23, 2023
|
PC3I Authors Ronac Mamtani |
BJUI Compass
|
|
Leveraging machine learning to identify acute myeloid leukemia patients and their chemotherapy regimens in an administrative database
|
February 23, 2023
|
PC3I Authors Alix Seif |
Pediatric Blood & Cancer
|
|
Creating research-ready partnerships: the initial development of seven implementation laboratories to advance cancer control
|
February 22, 2023
|
PC3I Authors Justin Bekelman |
BMC Health Services Research
|
|
Changes in mammographic density and risk of breast cancer among a diverse cohort of women undergoing mammography screening
|
February 17, 2023
|
PC3I Authors Anne Marie McCarthy |
Breast Cancer Research & Treatment
|
|
Comparison of Simulated Outcomes of Colorectal Cancer Surgery at the Highest-Performing vs Chosen Local Hospitals
|
February 15, 2023
|
PC3I Authors Shivan Mehta |
JAMA Network Open
|
|
Factors Associated With Primary Care Physician Decision-making When Making Medication Recommendations vs Surgical Referrals
|
February 15, 2023
|
PC3I Authors Shivan Mehta |
JAMA Network Open
|
|
TP53 in AML and MDS: The new (old) kid on the block
|
February 25, 2023
|
PC3I Authors Catherine Lai |
Blood Reviews
|
|
An investigational oral plasma kallikrein inhibitor for on-demand treatment of hereditary angioedema: a two-part, randomised, double-blind, placebo-controlled, crossover phase 2 trial
|
February 11, 2023
|
|
Lancet
|
|
ASO Author Reflections: Achieving Equity in Thyroid Cancer Treatment-More Work Ahead
|
February 10, 2023
|
|
Ann Surg Oncol
|
